News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
792,666 Results
Type
Article (56249)
Company Profile (344)
Press Release (736055)
Multimedia
Podcasts (229)
Webinars (32)
Section
Business (218492)
Career Advice (2927)
Deals (38340)
Drug Delivery (178)
Drug Development (87629)
Employer Resources (186)
FDA (17933)
Job Trends (16124)
News (372826)
Policy (35884)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (6)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (6)
Academia (2747)
Academic (1)
Accelerated approval (58)
ADA (48)
Adcomms (42)
Allergies (201)
Alliances (54687)
ALS (237)
Alzheimer's disease (1967)
Antibody-drug conjugate (ADC) (569)
Approvals (18325)
Artificial intelligence (846)
ASCO (344)
Autoimmune disease (378)
Automation (69)
Bankruptcy (385)
Best Places to Work (11940)
BIO (76)
BIOSECURE Act (23)
Biosimilars (256)
Biotechnology (221)
Bladder cancer (213)
Brain cancer (82)
Breast cancer (823)
Cancer (6583)
Cardiovascular disease (551)
Career advice (2499)
Career pathing (53)
CAR-T (388)
CDC (77)
Celiac Disease (2)
Cell therapy (1061)
Cervical cancer (57)
Clinical research (76310)
Collaboration (2407)
Commercialization (1)
Company closure (8)
Compensation (1547)
Complete response letters (108)
COVID-19 (2964)
CRISPR (124)
C-suite (1323)
Cystic fibrosis (165)
Data (8792)
Decentralized trials (3)
Denatured (81)
Depression (197)
Dermatology (101)
Diabetes (685)
Diagnostics (7219)
Digital health (65)
Diversity (14)
Diversity, equity & inclusion (45)
Drug discovery (416)
Drug pricing (247)
Drug shortages (38)
Duchenne muscular dystrophy (328)
Earnings (94457)
Editorial (80)
Employer branding (22)
Employer resources (165)
Events (129028)
Executive appointments (1204)
FDA (22120)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (36)
Funding (1954)
Gene editing (269)
Generative AI (77)
Gene therapy (835)
GLP-1 (1279)
Government (4842)
Grass and pollen (8)
Guidances (422)
Healthcare (19298)
Hematology (187)
HIV (97)
Huntington's disease (69)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (117)
Immunology and inflammation (363)
Immuno-oncology (118)
Indications (224)
Infectious disease (3365)
Inflammatory bowel disease (245)
Inflation Reduction Act (17)
Influenza (152)
Intellectual property (328)
Interviews (535)
IPO (17388)
IRA (61)
Job creations (4489)
Job search strategy (2055)
JPM (73)
Kidney cancer (23)
Labor market (122)
Layoffs (680)
Leadership (54)
Legal (8924)
Liver cancer (109)
Longevity (37)
Lung cancer (867)
Lymphoma (483)
Machine learning (68)
Management (65)
Manufacturing (1256)
Marketing (4)
MASH (229)
Medical affairs (1)
Medical device (14468)
Medtech (14641)
Mergers & acquisitions (22296)
Metabolic disorders (1819)
mRNA (268)
Multiple sclerosis (211)
NASH (24)
Neurodegenerative disease (512)
Neuropsychiatric disorders (130)
Neuroscience (3736)
Neurotech (2)
NextGen: Class of 2026 (6927)
Non-profit (4372)
Now hiring (83)
Obesity (880)
Opinion (373)
Ovarian cancer (249)
Pain (283)
Pancreatic cancer (366)
Parkinson's disease (423)
Partnered (38)
Patents (672)
Patient recruitment (802)
Peanut (69)
People (64723)
Pharmaceutical (88)
Pharmacy benefit managers (38)
Phase 1 (23681)
Phase 2 (33396)
Phase 3 (25210)
Pipeline (10123)
Policy (403)
Postmarket research (2919)
Preclinical (10021)
Press Release (70)
Prostate cancer (350)
Psychedelics (72)
Radiopharmaceuticals (373)
Rare diseases (1305)
Real estate (6838)
Recruiting (75)
Regulatory (28401)
Reports (60)
Research institute (2571)
Resumes & cover letters (459)
Rett syndrome (47)
RNA editing (30)
RSV (99)
Schizophrenia (195)
Series A (343)
Series B (250)
Service/supplier (16)
Sickle cell disease (129)
Special edition (33)
Spinal muscular atrophy (185)
Sponsored (54)
Startups (4098)
State (2)
Stomach cancer (21)
Supply chain (149)
Tariffs (104)
The Weekly (145)
Vaccines (1310)
Venture capital (142)
Weight loss (603)
Women's health (144)
Worklife (25)
Date
Today (114)
Last 7 days (553)
Last 30 days (2475)
Last 365 days (32078)
2026 (17180)
2025 (32038)
2024 (36828)
2023 (41665)
2022 (52762)
2021 (57287)
2020 (55710)
2019 (48191)
2018 (36485)
2017 (34976)
2016 (35411)
2015 (41028)
2014 (35597)
2013 (30186)
2012 (32168)
2011 (32479)
2010 (31105)
Location
Africa (960)
Alabama (101)
Alaska (7)
Arizona (393)
Arkansas (15)
Asia (47452)
Australia (7712)
California (14374)
Canada (3996)
China (1615)
Colorado (606)
Connecticut (639)
Delaware (447)
Europe (107758)
Florida (2161)
Georgia (463)
Hawaii (4)
Idaho (70)
Illinois (1220)
India (105)
Indiana (658)
Iowa (25)
Japan (620)
Kansas (137)
Kentucky (55)
Louisiana (54)
Maine (87)
Maryland (1731)
Massachusetts (10475)
Michigan (401)
Minnesota (792)
Mississippi (7)
Missouri (158)
Montana (36)
Nebraska (31)
Nevada (152)
New Hampshire (87)
New Jersey (3800)
New Mexico (33)
New York (3792)
North Carolina (1894)
North Dakota (11)
Northern California (7219)
Ohio (439)
Oklahoma (24)
Oregon (47)
Pennsylvania (2782)
Puerto Rico (33)
Rhode Island (53)
South America (1376)
South Carolina (89)
South Dakota (2)
Southern California (5697)
Tennessee (233)
Texas (2312)
United States (51085)
Utah (406)
Vermont (2)
Virginia (364)
Washington D.C. (87)
Washington State (1148)
West Virginia (4)
Wisconsin (154)
Wyoming (2)
792,666 Results for "biopharma solutions baxter s pharma biotech partnering business".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug pricing
BIO 2026: Biopharma dealmakers seek to protect ‘premium pricing’ from Trump’s MFN policy
With drug pricing now embedded in U.S. policy, business development teams in biotech and pharma are changing the way they strike deals, including acknowledging policy uncertainties with renegotiation clauses.
June 23, 2026
·
2 min read
·
Annalee Armstrong
IPO
BIO 2026: Making biotech IPOs great again and the forgotten pharma antitrust review
Dealmaking across biopharma is shifting dramatically as the SEC rolls out new regulations to ease burdens on newly public companies and antitrust review is replaced by drug pricing as the policy concern du jour.
June 26, 2026
·
3 min read
·
Annalee Armstrong
Podcast
Moderna’s FDA adcomm, IPO mania, biopharma layoffs, more
Moderna appears to have aligned with the FDA ahead of an advisory committee meeting for its mRNA-based flu vaccine, which the regulator initially turned away in February; biotech IPOs are going gangbusters, including two new records raises in as many weeks; layoffs continue across biopharma; plus much more.
June 17, 2026
·
2 min read
·
Jef Akst
Career Advice
Should biopharma professionals negotiate job offers in an employer’s market?
Three experts discuss whether biotech and pharma professionals should try to convince employers to adjust employment offers, mistakes people make during the process and tips for getting it right.
May 28, 2026
·
6 min read
·
Angela Gabriel
Mergers & acquisitions
Pharma Double-Dippers Lead Q1 Deal Activity to Nearly $47B
Deal-hungry Big Pharmas, a long-sought biotech prize, an infrequent buyer and one serial biotech rabblerouser highlight a busy quarter in biopharma M&A.
April 1, 2026
·
1 min read
·
Annalee Armstrong
Business
Sanofi’s R&D head exits, with AI biotech Xaira’s exec stepping in
About two months into CEO Belén Garijo’s new tenure, Sanofi’s R&D chief has departed, with Xaira’s chief medical officer set to take charge of the pharma’s pipeline.
June 22, 2026
·
1 min read
·
Gabrielle Masson
Business
Big Pharma restructures to ride out ‘existential risk’
Even biopharma’s biggest players have been forced to take a hard look at their businesses and realign their cost structures to cope with the continued and compounding challenges plaguing the industry.
June 24, 2026
·
10 min read
·
Tristan Manalac
Mergers & acquisitions
Lilly’s $25B+ M&A spree captures half of pharma’s 2026 capacity
Over the past decade, Eli Lilly has bought out more biotechs than any of the other top 12 pharmas by revenue—with 10 of those acquisitions arriving just this year.
June 10, 2026
·
1 min read
·
Annalee Armstrong
China
No longer a bargain pool, Chinese biotechs command higher premiums
Deal dynamics between Chinese biotechs and global pharma companies are changing fast, with the biotechs seeking higher upfront payments and the Big Pharmas seeking more expansive platform deals.
June 3, 2026
·
5 min read
·
Leslie Zhen Liang
Mergers & acquisitions
PwC declares biopharma ecosystem ‘back to full health’ as M&A buoys sector
Precision science is ruling the M&A scene as pharmas prepare for loss of exclusivity on key products, PwC says in a new report. Biotechs should be prepared with a dual-track process with the IPO window now open.
June 17, 2026
·
2 min read
·
Annalee Armstrong
1 of 79,267
Next
